Yashica Pharmaceuticals
Yashica Pharmaceuticals
Yashica Pharmaceuticals

Yashica Pharmaceuticals


Yashica PharmaceuticalsYashica Pharmaceuticals

Home » Finished Formulation » Doxycycline Capsules

Doxycycline Capsules

Our company is able to gain appreciation and recognition in the medical industry in offering clinically tested array of Yashicycline Capsules-insert and it contain doxycycline hyclate, a broad spectrum antibiotic synthetically derived from oxytetracycline. It is used in the treatment of bacterial infections by controlling the growth of bacteria. The capsules are offered in 100 mg strength capacity.

  • Each hard gelatin capsule contains: doxycycline hyclate BP, Eq. to doxycycline 100 mg, excipients q s
  • Approved colour used in empty capsule shell.
Indications and usage:
  • Yashicycline should be used only to treat or pervert infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting on modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
  • The drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.
  • The use of drugs of the tetracycline class during tooth development (last half of pregnancy, infancy and childhood to the age of 8 years) may cause permanent discolouration of teeth (yellow- gray-brown). This adverse reaction is more common during long-term use of the drug but it has been observed following repeated short-term courses. Enamel hypoplasia also may occur. Tetracycline drugs therefore should not be used in these age groups except for anthrax, including inhalation anthrax (post-exposure), unless other drugs are not likely to be effective or are contraindicated.
  • General: As with other antibiotic preparations, use of this drug may result in overgrowth of non- susceptible organisms, including fungi. If super-infection occurs, the antibiotic should be discontinued and appropriate therapy should be instituted. Bulging fontanels in infants and benign intracranial hypertension in adults may occur. These conditions disappear when the drug is discontinued. Incision and drainage or other surgical procedures should be performed in conjunction with antibiotic therapy when indicated. Doxycycline offers substantial but not complete suppression of the asexual blood stages of Plasmodium strains.
  • Store in cool & dry place
  • Keep out of reach of children

Yes! I am Interested

Yashica Pharmaceuticals

Our Product Range :     Active Pharmaceuticals Ingredients |Drug Intermediates | Finished Formulation

Home|About Us|Our Product Range|Media Gallery|Contact Us|Enquiry

Member INDIAMART© Yashica Pharmaceuticals Private Limited. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited

Looking for Product Name ?


Send SMS Enquiry

*Please Enter Requirment

*Please Enter valid Mobile Number

*Please Enter Proper Name